Lack of Correlation Between P-glycoprotein and Chemotherapy Resistance in Nasal NK/T-cell Lymphomas

References

• Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., et al. (1999) "World Health Organization classification of neoplastic diseases of the hemato-poietic and lymphoid tissues: Report of the clinical advisory committee meeting—Airlie House, Virgina, November 1997", J. Clin. Oncol., 17, 3835–3849.
   Google Scholar
• Jaffe, E.S., Chan, J.K.C., Su, I.J., Frizzera, G., Mori, S., Feller, A.C., et al. (1996) "Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas—defini-tions, differential diagnosis and epidemiology", Amer. J. Surg. Pathol., 20, 103–111.
   Google Scholar
• Cuadra-Garcia, I., Proulx, G.M., Wu, C.L., Wang, C.C., Pilch, B.Z., Harris, N.L., et al. (1999) "Sinonasal lymphoma: A clinicopathologic analysis of 58 cases from the Massachusetts General Hospital", Amer. J. Surg. Pathol., 23, 1356— 1369.
   Google Scholar
• Cheung, M.M.C., Chan, J.K.C., Lau, W.H., Foo, W., Chan, P.T.M., Ng, CS., et al. (1998) "Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophe-notype, and treatment outcome in 113 patients", J. Clin. Oncol., 16, 70 — 77.
   Google Scholar
• Ribrag, V., Hajj, E.M., Janot, F., Girinsky, T., Domenge, C., Schwaab, G., et al. (2001) "Early locoregional high-dose radio-therapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharyruc", Leukemia, 15, 1123–1126.
   Google Scholar
• Lei, K.I.K., Suen, J.J.S., Hui, P., Ton, M., Li, W. and Yau, S.H. (1999) "Primary nasal and nasopharyngeal lymphomas: A com-parative study of clinical presentation and treatment outcome", Clin. Oncol., 11, 379–387.
   Google Scholar
• Kim, G.E., Lee, SM., Chang, S.K., Park, H.C., Pyo, H.R., Kim, J.H., et al. (2001) "Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck", Radiother. Oncol., 61, 261–269.
   Google Scholar
• Kim, W.S., Song, S.Y., Ahn, Y.C., Ko, Y.H., Baek, C.H., Kim, D.Y., etal. (2001) "CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma"? Ann. Oncol., 12, 349 — 352.
   Google Scholar
• Yamaguchi, M., Kita, K., Miwa, H., Nishii, K., Oka, K., Ohno, T., et al. (1995) "Frequent expression of P-glycoprotein/ MDR1 by nasal T-cell lymphoma cells", Cancer, 76, 2351–2356.
   Google Scholar
• Drenou, B., Lamy, T., Amiot, L., Fardel, 0., Caulet-Maugendre, S., Sasportes, M., et al. (1997) "CD3 — CD56 + non-Hodgkin lymphomas with an aggressive behavior related to multidrug resistance", Blood, 89, 2965–2974.
   Google Scholar
• Goldstein, L.J. (1996) "MDR1 gene expression in solid tumours", Eur. J. Cancer, 32A, 1030— 1050.
   Google Scholar
• Liang, V. (1992) "P-glycoprotein and resistance to anticancer drugs", Cancer, 69, 2603–2609.
   Google Scholar
• Marie, J.P. (1995) "P-glycoprotein in adult hematologic malignan-cies", Hematol. Oncol. Clin. North Amer., 9, 239–249.
   Google Scholar
• Chaudhary, P.M., Mechetner, E.B. and Roninson, I.B. (1992) "Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes", Blood, 80, 2735 —2739.
   Google Scholar
• Kobayashi, Y., Yamashiro, T., Nagatake, H., Yamamoto, T., Watanabe, N., Tanaka, H., et al. (1994) "Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52", Biochem. Pharmacol., 48, 1641 — 1646.
   Google Scholar
• Egashira, M., Kawamata, N., Sugimoto, K., Kaneko, T. and Oshimi, K. (1999) "P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC 833", Blood, 93, 599 — 606.
   Google Scholar
• Kim, G.E., Yang, W.I., Lee, SM., et al. (2001) "The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck", Cancer, 91, 2343–2352.
   Google Scholar
• Yuen, A.R. and Sikic, B.I. (1994) "Multidrug resistance in lymphomas", J. Clin. Oncol., 12, 2453–2459.
   Google Scholar
• Lehnert, M. (1996) "Clinical multidrug resistance in cancer: A multifactorial problem", Eur. J. Cancer, 6, 912–920.
   Google Scholar
• Beck, W.T., Grogan, T.M., William, C.L., et al. (1996) "Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumor: Consensus recommendations", Cancer Res., 56, 3010— 3020.
   Google Scholar
• Cheung, A.L., Su, I.J., Chen, Y.C., Lee, T.C. and Wong, C.H. (1993) "Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: The possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors", J. Clin. Oncol., 11, 109 — 115.
   Google Scholar
• Natkunam, Y., Smoller, B.R., Zehnder, J.L., Dorfman, R.F. and Warnke, R.A.. (1999) "Aggressive cutaneous NK and NK-like T-cell lymphomas: Clinicopathologic, immunohistochemical, and molecular analysis of 12 cases", Amer. J. Surg. Pathol., 23, 571 — 581.
   Google Scholar
• Raghu, G., Park, S.W., Roninson, I.B. and Mechetner, E.B. (1996) "Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lympho-cytes", Exp. Hematol., 24, 1258 — 1264.
   Google Scholar
• Drenou, B., Amiot, L., Lamy, T., Prise, P.L. and Pauchet, R. (1998) "Multidrug resistance in aggressive lymphoproliferative disorder of T and natural-killer origin", Leuk. Lymphoma, 30, 381 —387.
   Google Scholar
• Filipits, M., Jaeger, U., Simonitsch, I., Cl-dzzali-Bonfadin, C., Heinzi, H. and Pirker, R. (2000) "Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas", Clin. Cancer Res., 6, 3417–3423.
   Google Scholar
• Ohno, N., Tani, A., Chen, Z.S., Uozumi, K., Hanada, S., Alciba, S., et al. (2000) "Prognostic significance of multidrug resistance protein in adult T-cell leukemia", Clin. Cancer Res., 7, 3120–3126.
   Google Scholar
• Lamy, T., Drenou, B., Fardel, 0., Amiot, L., Grulois, I., Prise, P.L., et al. (1998) "Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes", Br. J. Hematol., 100, 509 — 515.
   Google Scholar
• Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, C.E., Almquist, K.C., etal. (1992) "Overexpression of a transporter in a mutidrug-resistant human lung cancer cell lines", Science, 258, 1650— 1654.
   Google Scholar
• Trambas, C., Wang, Z., Cianefriglia, M. and Woods, G. (2001) "Evidence that natural killer cells express mini P-glycoproteins but not classic 170kDa P-glycoprotein", Br. J. Hematol., 114, 177 — 184.
   Google Scholar